William Devaul
General Counsel, Corporate Secretary and Chief Compliance Officer at Morphic Therapeutic | Waltham, Massachusetts, United States
William Devaul’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
ContactOut Insights • AI Generated
William Devaul serves as General Counsel, Corporate Secretary, and Chief Compliance Officer at Morphic Therapeutic, overseeing legal, corporate governance, and regulatory compliance for a biotechnology company focused on oral integrin therapies for immunological, fibrotic, neoplastic, and vascular diseases. He previously advanced within the organization from General Counsel and Corporate Secretary while supporting its mission to build upon decades of research into integrin receptor targets pioneered by founder Tim Springer. A Boston University School of Law alumnus, he provides strategic legal counsel from the company’s Waltham, Massachusetts base to advance its therapeutic pipeline.
BEST APPROACH TO REACH William Devaul
Reach out through LinkedIn using a personalized InMail that references his dual oversight of legal compliance and corporate governance at Morphic Therapeutic, positioning a brief introductory discussion around regulatory strategy or executive leadership needs.
General Counsel, Corporate Secretary and Chief Compliance Officer at Morphic Therapeutic in February 2019 - December 2024
Vice President, Intellectual Property at Evelo Biosciences in May 2015 - February 2019
Deputy Chief Intellectual Property Counsel at Cubist Pharmaceuticals in March 2014 - February 2015
Associate General Counsel, Disputes, Intellectual Property Strategy, and Transactions at Cubist Pharmaceuticals in May 2013 - March 2014
Associate General Counsel, Intellectual Property and Litigation at Cubist Pharmaceuticals in January 2009 - May 2013
Senior Intellectual Property Counsel at Cubist Pharmaceuticals in January 2006 - December 2008
Intellectual Property Counsel at Cubist Pharmaceuticals in January 2003 - January 2006
Senior Associate at Foley Hoag LLP in January 2001 - January 2003
Associate at Lahive & Cockfield LLP in January 1999 - January 2001
Associate at Rogers & Wells, LLP in January 1998 - January 1999
Associate at Cooper & Dunham LLP in January 1996 - January 1998
Boston University School of Law, J.D., October 1993 to October 1996
Columbia University, B.A., October 1988 to October 1992
Coral Gables Senior High, October 1988
Oral integrin therapies for patients with immunological, fibrotic, neoplastic and vascular diseases. Morphic Tx is joining a three decade quest led by our scientific founder, Tim Springer, who initially discovered the integrin receptor family in the 1980s. This receptor family is an important drug target that has fueled the successful development of six injectable therapies approved for treatment of multiple sclerosis, ulcerative colitis, Crohn's disease, plaque psoriasis, acute coronary syndrome and complications during percutaneous coronary intervention. Despite blockbuster commercial success, integrins have remained out of reach as small molecule drugs...until now.
Discover more about Morphic Therapeutic
Principal Scientist at Eli Lilly and Company
Senior Research Associate at Morphic Therapeutic
(January 2022 – Present)
SVP, Regulatory Affairs and Quality at Morphic Therapeutic
SVP Regulatory Affairs & Quality at Morphic Therapeutic
(Apr 2022 – Present)
SVP at Morphic Therapeutic
Communications and Strategy Advisory for the Life Sciences
Bioinformatics Leader @ Morphic Therapeutic | PhD, Clinical Data, Computational Analysis
- Heading bioinformatics team that supports pre/post-clinical data analytics, validations and biomarker discovery
- Leading scRNAseq, Spatial Trx, Proteomics, Genomics data operations to support cross-functional data interpretations/ value generation
Director, HR/People Operations @ Morphic | SHRM-SCP, SPHR
Oral integrin therapies for patients with immunological, fibrotic, neoplastic and vascular diseases; 130+ employees.
- Director, HR/People Operations | January 2024 – Present
- Senior Manager, HR/People Operations | January 2022 – December 2023
- Manager, HR/People Operat...
Principal Scientist at Morphic Therapeutic
What is William Devaul email address?
Email William Devaul at [email protected], [email protected] and [email protected]. This email is the most updated William Devaul's email found in 2026.
What is William Devaul phone number?
William Devaul phone number is (617) 364-8446, +16179220155 and 6073486601.
How to contact William Devaul?
To contact William Devaul send an email to [email protected], [email protected] or [email protected]. If you want to call William Devaul try calling on (617) 364-8446, +16179220155 and 6073486601. (updated on September 16, 2025)
What company does William Devaul work for?
William Devaul works for Morphic Therapeutic.
What is William Devaul's role at Morphic Therapeutic?
William Devaul is General Counsel, Corporate Secretary and Chief Compliance Officer
What industry does William Devaul work in?
William Devaul works in the Biotechnology industry.
